Sandy Draper
Stock Analyst at Guggenheim
(3.51)
# 918
Out of 4,711 analysts
125
Total ratings
55%
Success rate
16.62%
Average return
Main Sectors:
Stocks Rated by Sandy Draper
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MEDP Medpace Holdings | Maintains: Buy | $464 → $432 | $337.28 | +28.08% | 12 | Jul 24, 2024 | |
| ACCD Accolade | Maintains: Buy | $13 → $6 | $3.48 | +72.41% | 5 | Jun 28, 2024 | |
| IQV IQVIA Holdings | Downgrades: Neutral | n/a | $197.27 | - | 8 | Feb 15, 2024 | |
| CRL Charles River Laboratories International | Downgrades: Neutral | n/a | $185.77 | - | 15 | Feb 15, 2024 | |
| EVH Evolent Health | Maintains: Hold | $36 → $34 | $11.41 | +197.98% | 9 | Nov 14, 2023 | |
| GDRX GoodRx Holdings | Maintains: Buy | $8 → $10 | $4.44 | +125.23% | 4 | Aug 10, 2023 | |
| DOCS Doximity | Downgrades: Neutral | n/a | $57.83 | - | 3 | Aug 9, 2023 | |
| TOI The Oncology Institute | Maintains: Buy | $3 → $2 | $0.21 | +851.93% | 3 | Jun 16, 2023 | |
| ICLR ICON Public Limited Company | Maintains: Buy | $271 → $263 | $207.51 | +26.74% | 13 | Apr 28, 2023 | |
| AGL agilon health | Maintains: Buy | $21 → $30 | $1.97 | +1,422.84% | 3 | Mar 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $89 → $94 | $94.95 | -1.00% | 11 | Dec 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | n/a | $9.44 | - | 10 | Oct 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $51 | $20.07 | +154.11% | 2 | Aug 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $143 → $129 | $161.88 | -20.31% | 2 | May 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $84 → $55 | $40.89 | +34.51% | 2 | May 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $226 → $168 | $59.40 | +182.83% | 2 | May 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $12 | $26.20 | -54.20% | 1 | Apr 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $180 | $0.77 | +23,276.62% | 1 | Mar 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $33 → $38 | $21.76 | +74.63% | 7 | Feb 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $50 | $5.75 | +769.57% | 1 | Jan 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $65 | $16.41 | +296.10% | 1 | Jan 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $36 | $7.09 | +407.76% | 4 | May 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $175 → $167 | $224.15 | -25.50% | 3 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $1.49 | - | 2 | May 31, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $63 | $17.51 | +259.79% | 1 | Sep 20, 2016 |
Medpace Holdings
Jul 24, 2024
Maintains: Buy
Price Target: $464 → $432
Current: $337.28
Upside: +28.08%
Accolade
Jun 28, 2024
Maintains: Buy
Price Target: $13 → $6
Current: $3.48
Upside: +72.41%
IQVIA Holdings
Feb 15, 2024
Downgrades: Neutral
Price Target: n/a
Current: $197.27
Upside: -
Charles River Laboratories International
Feb 15, 2024
Downgrades: Neutral
Price Target: n/a
Current: $185.77
Upside: -
Evolent Health
Nov 14, 2023
Maintains: Hold
Price Target: $36 → $34
Current: $11.41
Upside: +197.98%
GoodRx Holdings
Aug 10, 2023
Maintains: Buy
Price Target: $8 → $10
Current: $4.44
Upside: +125.23%
Doximity
Aug 9, 2023
Downgrades: Neutral
Price Target: n/a
Current: $57.83
Upside: -
The Oncology Institute
Jun 16, 2023
Maintains: Buy
Price Target: $3 → $2
Current: $0.21
Upside: +851.93%
ICON Public Limited Company
Apr 28, 2023
Maintains: Buy
Price Target: $271 → $263
Current: $207.51
Upside: +26.74%
agilon health
Mar 6, 2023
Maintains: Buy
Price Target: $21 → $30
Current: $1.97
Upside: +1,422.84%
Dec 7, 2022
Maintains: Buy
Price Target: $89 → $94
Current: $94.95
Upside: -1.00%
Oct 24, 2022
Upgrades: Neutral
Price Target: n/a
Current: $9.44
Upside: -
Aug 12, 2022
Maintains: Buy
Price Target: $36 → $51
Current: $20.07
Upside: +154.11%
May 25, 2021
Maintains: Buy
Price Target: $143 → $129
Current: $161.88
Upside: -20.31%
May 18, 2021
Maintains: Buy
Price Target: $84 → $55
Current: $40.89
Upside: +34.51%
May 12, 2021
Maintains: Buy
Price Target: $226 → $168
Current: $59.40
Upside: +182.83%
Apr 21, 2021
Initiates: Hold
Price Target: $12
Current: $26.20
Upside: -54.20%
Mar 29, 2021
Initiates: Buy
Price Target: $180
Current: $0.77
Upside: +23,276.62%
Feb 4, 2021
Maintains: Hold
Price Target: $33 → $38
Current: $21.76
Upside: +74.63%
Jan 28, 2021
Initiates: Buy
Price Target: $50
Current: $5.75
Upside: +769.57%
Jan 28, 2021
Initiates: Buy
Price Target: $65
Current: $16.41
Upside: +296.10%
May 13, 2020
Maintains: Buy
Price Target: $30 → $36
Current: $7.09
Upside: +407.76%
Mar 26, 2020
Maintains: Buy
Price Target: $175 → $167
Current: $224.15
Upside: -25.50%
May 31, 2017
Upgrades: Buy
Price Target: n/a
Current: $1.49
Upside: -
Sep 20, 2016
Initiates: Buy
Price Target: $63
Current: $17.51
Upside: +259.79%